{"title":"基于多功能Ta@Sr2+的巨噬基因通过调节软骨形成和巨噬细胞极化缓解骨关节炎","authors":"Hongjiang Liu, Kunmu Yang, Zengqiang Yang, Xingbao Lu, Jian Wu, Yong Cui","doi":"10.1002/jbm.a.37958","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Osteoarthritis (OA) is a progressive joint disease that involves damage to the cartilage, inflammation in the synovium, and injury to the subchondral bone, which highlights the need for the creation of novel treatment options. Nevertheless, finding an effective method that combines anti-inflammatory properties with the ability to regenerate cartilage remains a significant challenge. TA@Sr<sup>2+</sup> is a bioactive coordination complex formed through chelation between tannic acid (TA) and strontium ions (Sr<sup>2+</sup>), exhibiting a hierarchically structured metal-phenolic network. This research presents an innovative strategy utilizing a Macrophage<sub>nex</sub> developed from multifunctional TA@Sr<sup>2+</sup>, which promotes chondrogenesis and exhibits strong anti-inflammatory effects. The Macrophage<sub>nex</sub> based on TA@Sr<sup>2+</sup> is constructed by self-assembling a single-cell layer using varying concentrations of TA and Sr<sup>2+</sup> on RAW264.7 cell surfaces. This Macrophage<sub>nex</sub> demonstrates robust biological activity, enhancing chondrocyte proliferation, differentiation, and migration, alongside the upregulation of anabolic genes such as aggrecan (ACAN) and collagen II, while simultaneously inhibiting the expression of catabolic genes like MMP13 in a dose-dependent manner under LPS-induced inflammation. In addition, TA@Sr<sup>2+</sup> reduces the expression of proinflammatory cytokines (TNF-α and IL-6) in macrophages and promotes their polarization to the anti-inflammatory M2 phenotype. These results suggest that TA@Sr<sup>2+</sup> has significant promise for treating OA by regulating both chondrogenesis and macrophage polarization simultaneously.</p>\n </div>","PeriodicalId":15142,"journal":{"name":"Journal of biomedical materials research. Part A","volume":"113 8","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Macrophagenex Based on Multifunctional Ta@Sr2+ Alleviates Osteoarthritis by Modulating Chondrogenesis and Macrophage Polarization\",\"authors\":\"Hongjiang Liu, Kunmu Yang, Zengqiang Yang, Xingbao Lu, Jian Wu, Yong Cui\",\"doi\":\"10.1002/jbm.a.37958\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p>Osteoarthritis (OA) is a progressive joint disease that involves damage to the cartilage, inflammation in the synovium, and injury to the subchondral bone, which highlights the need for the creation of novel treatment options. Nevertheless, finding an effective method that combines anti-inflammatory properties with the ability to regenerate cartilage remains a significant challenge. TA@Sr<sup>2+</sup> is a bioactive coordination complex formed through chelation between tannic acid (TA) and strontium ions (Sr<sup>2+</sup>), exhibiting a hierarchically structured metal-phenolic network. This research presents an innovative strategy utilizing a Macrophage<sub>nex</sub> developed from multifunctional TA@Sr<sup>2+</sup>, which promotes chondrogenesis and exhibits strong anti-inflammatory effects. The Macrophage<sub>nex</sub> based on TA@Sr<sup>2+</sup> is constructed by self-assembling a single-cell layer using varying concentrations of TA and Sr<sup>2+</sup> on RAW264.7 cell surfaces. This Macrophage<sub>nex</sub> demonstrates robust biological activity, enhancing chondrocyte proliferation, differentiation, and migration, alongside the upregulation of anabolic genes such as aggrecan (ACAN) and collagen II, while simultaneously inhibiting the expression of catabolic genes like MMP13 in a dose-dependent manner under LPS-induced inflammation. In addition, TA@Sr<sup>2+</sup> reduces the expression of proinflammatory cytokines (TNF-α and IL-6) in macrophages and promotes their polarization to the anti-inflammatory M2 phenotype. These results suggest that TA@Sr<sup>2+</sup> has significant promise for treating OA by regulating both chondrogenesis and macrophage polarization simultaneously.</p>\\n </div>\",\"PeriodicalId\":15142,\"journal\":{\"name\":\"Journal of biomedical materials research. Part A\",\"volume\":\"113 8\",\"pages\":\"\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-08-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of biomedical materials research. Part A\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jbm.a.37958\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part A","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbm.a.37958","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Macrophagenex Based on Multifunctional Ta@Sr2+ Alleviates Osteoarthritis by Modulating Chondrogenesis and Macrophage Polarization
Osteoarthritis (OA) is a progressive joint disease that involves damage to the cartilage, inflammation in the synovium, and injury to the subchondral bone, which highlights the need for the creation of novel treatment options. Nevertheless, finding an effective method that combines anti-inflammatory properties with the ability to regenerate cartilage remains a significant challenge. TA@Sr2+ is a bioactive coordination complex formed through chelation between tannic acid (TA) and strontium ions (Sr2+), exhibiting a hierarchically structured metal-phenolic network. This research presents an innovative strategy utilizing a Macrophagenex developed from multifunctional TA@Sr2+, which promotes chondrogenesis and exhibits strong anti-inflammatory effects. The Macrophagenex based on TA@Sr2+ is constructed by self-assembling a single-cell layer using varying concentrations of TA and Sr2+ on RAW264.7 cell surfaces. This Macrophagenex demonstrates robust biological activity, enhancing chondrocyte proliferation, differentiation, and migration, alongside the upregulation of anabolic genes such as aggrecan (ACAN) and collagen II, while simultaneously inhibiting the expression of catabolic genes like MMP13 in a dose-dependent manner under LPS-induced inflammation. In addition, TA@Sr2+ reduces the expression of proinflammatory cytokines (TNF-α and IL-6) in macrophages and promotes their polarization to the anti-inflammatory M2 phenotype. These results suggest that TA@Sr2+ has significant promise for treating OA by regulating both chondrogenesis and macrophage polarization simultaneously.
期刊介绍:
The Journal of Biomedical Materials Research Part A is an international, interdisciplinary, English-language publication of original contributions concerning studies of the preparation, performance, and evaluation of biomaterials; the chemical, physical, toxicological, and mechanical behavior of materials in physiological environments; and the response of blood and tissues to biomaterials. The Journal publishes peer-reviewed articles on all relevant biomaterial topics including the science and technology of alloys,polymers, ceramics, and reprocessed animal and human tissues in surgery,dentistry, artificial organs, and other medical devices. The Journal also publishes articles in interdisciplinary areas such as tissue engineering and controlled release technology where biomaterials play a significant role in the performance of the medical device.
The Journal of Biomedical Materials Research is the official journal of the Society for Biomaterials (USA), the Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials.
Articles are welcomed from all scientists. Membership in the Society for Biomaterials is not a prerequisite for submission.